- Home
- GP vs AIMD Comparison
GP vs AIMD Comparison
Compare GP & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GP
- AIMD
- Stock Information
- Founded
- GP 2010
- AIMD 1984
- Country
- GP Canada
- AIMD United States
- Employees
- GP 113
- AIMD N/A
- Industry
- GP Construction/Ag Equipment/Trucks
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- GP Consumer Discretionary
- AIMD Health Care
- Exchange
- GP Nasdaq
- AIMD Nasdaq
- Market Cap
- GP 10.5M
- AIMD 11.9M
- IPO Year
- GP 2020
- AIMD N/A
- Fundamental
- Price
- GP $0.35
- AIMD $3.26
- Analyst Decision
- GP Strong Buy
- AIMD
- Analyst Count
- GP 2
- AIMD 0
- Target Price
- GP $2.33
- AIMD N/A
- AVG Volume (30 Days)
- GP 4.1M
- AIMD 7.1M
- Earning Date
- GP 08-22-2025
- AIMD 08-22-2025
- Dividend Yield
- GP N/A
- AIMD N/A
- EPS Growth
- GP N/A
- AIMD N/A
- EPS
- GP N/A
- AIMD N/A
- Revenue
- GP $19,847,279.00
- AIMD $106,207.00
- Revenue This Year
- GP $81.12
- AIMD N/A
- Revenue Next Year
- GP $91.69
- AIMD N/A
- P/E Ratio
- GP N/A
- AIMD N/A
- Revenue Growth
- GP N/A
- AIMD 13.38
- 52 Week Low
- GP $0.28
- AIMD $2.00
- 52 Week High
- GP $1.90
- AIMD $5.00
- Technical
- Relative Strength Index (RSI)
- GP 44.75
- AIMD 62.08
- Support Level
- GP $0.28
- AIMD $2.25
- Resistance Level
- GP $0.64
- AIMD $3.64
- Average True Range (ATR)
- GP 0.07
- AIMD 0.34
- MACD
- GP -0.00
- AIMD 0.08
- Stochastic Oscillator
- GP 20.66
- AIMD 44.89
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.